Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for tough lymphomas: japanese trial tests golcadomide

NCT ID NCT06035497

Ongoing Disease control Sponsor: Bristol-Myers Squibb Source: ClinicalTrials.gov ↗

First seen Apr 29, 2026 · Last updated May 22, 2026 · Updated 6 times

Summary

This study is testing a new drug called Golcadomide (BMS-986369) in 85 people in Japan whose T-cell lymphoma has returned or stopped responding to treatment. The goal is to see if the drug is safe, tolerable, and effective at shrinking tumors. The study has two phases: first checking safety and dosing, then measuring how well the drug works against different types of T-cell lymphoma.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RELAPSED OR REFRACTORY T-CELL LYMPHOMAS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Local Institution - 0001

    Sendai, Miyagi, 980-8574, Japan

  • Local Institution - 0002

    Kashiwa, Chiba, 277-8577, Japan

  • Local Institution - 0003

    Chuo-ku, Tokyo, 104-0045, Japan

  • Local Institution - 0004

    Isehara, Kanagawa, 259-1193, Japan

  • Local Institution - 0005

    Ōsaka-sayama, Osaka, 589-8511, Japan

  • Local Institution - 0006

    Kumamoto, 860-8556, Japan

  • Local Institution - 0007

    Okayama, 700-8558, Japan

  • Local Institution - 0008

    Kagoshima, 890-8520, Japan

  • Local Institution - 0009

    Hidaka, Saitama, 350-1298, Japan

  • Local Institution - 0010

    Osaka, 541-8567, Japan

  • Local Institution - 0011

    Nagoya, Aichi-ken, 467-8602, Japan

  • Local Institution - 0012

    Fukuoka, 812-8582, Japan

  • Local Institution - 0013

    Yokosuka, Kanagawa, 238-8558, Japan

  • Local Institution - 0015

    Kagoshima, 890-0064, Japan

  • Local Institution - 0016

    Iizuka, Fukuoka, 820-8505, Japan

  • Local Institution - 0017

    Kamogawa, Chiba, 296-0041, Japan

  • Local Institution - 0018

    Fukuoka, 810-8563, Japan

  • Local Institution - 0019

    Ōmura, Nagasaki, 8568562, Japan

  • Local Institution - 0020

    Ōita, 870-8511, Japan

  • Local Institution - 0022

    Mitaka, 181-8611, Japan

  • Local Institution - 0023

    Fukuoka, 814-0180, Japan

  • Local Institution - 0024

    Toyohashi, Aichi-ken, 441-8570, Japan

  • Local Institution - 0025

    Hiroshima, 7348551, Japan

  • Local Institution - 0026

    Minato-ku, Tokyo, 105-8471, Japan

  • Local Institution - 0027

    Kyoto, 602-8566, Japan

  • Local Institution - 0028

    Sasebo, Nagasaki, 857-8511, Japan

  • Local Institution - 0029

    Itabashiku, Tokyo, 173-8610, Japan

  • Local Institution - 0030

    Nagasaki, 852-8104, Japan

  • Local Institution - 0031

    Anjo-shi, Aichi-ken, 446-8602, Japan

  • Local Institution - 0032

    Amagasaki, Hyōgo, 660-8550, Japan

  • Local Institution - 0033

    Kobe, Hyōgo, 650-0047, Japan

  • Local Institution - 0034

    Osaka, 545-8586, Japan

  • Local Institution - 0035

    Kumamoto, 860-0008, Japan

  • Local Institution - 0036

    Sapporo, Hokkaido, 0608648, Japan

  • Local Institution - 0037

    Narita, Chiba, 286-8520, Japan

  • Local Institution - 0038

    Miyazaki, 889-1692, Japan

  • Local Institution - 0039

    Hiroshima, 730-0052, Japan

  • Local Institution - 0040

    Koto, Tokyo, 135-8550, Japan

  • Local Institution - 0041

    Kitakyushu-shi, Fukuoka, 806-8501, Japan

  • Local Institution - 0042

    Okinawa, 904-2142, Japan

Conditions

Explore the condition pages connected to this study.

RELAPSED OR REFRACTORY T-CELL LYMPHOMAS